Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $10.41B | $9.68B | +7.54% |
Operating Income | $3B | $3.07B | -2.40% |
Net Income | $3.49B | $2.79B | +25.09% |
EPS (Basic) | $32.36 | $26.16 | +23.70% |
EPS (Diluted) | $30.23 | $24.57 | +23.04% |
R&D Expense | $3.72B | $3.26B | +14.04% |
SG&A Expense | $2.16B | $1.89B | +14.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $37.44B | $32.16B | +16.41% |
Current Assets | $19.33B | $18.63B | +3.75% |
Total Liabilities | $8.12B | $7.26B | +11.81% |
Current Liabilities | $3.66B | $3.6B | +1.73% |
Stockholders' Equity | $29.33B | $24.9B | +17.75% |
Cash & Equivalents | $2.01B | $2.15B | -6.53% |
Long-Term Debt | $1.98B | $1.98B | +0.07% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.16B | $3.5B | -9.89% |
Investing Cash Flow | $-2.82B | $-3.12B | +9.63% |
Financing Cash Flow | $-1.06B | $-1.34B | +20.76% |
Dividends Paid | $0 | — | — |
Share Buybacks | $1.63B | $1.95B | -16.22% |
D&A | $356.5M | $308M | +15.75% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 28.8% | 31.7% | -2.93% |
Net Margin | 33.6% | — | — |
ROE | 11.9% | — | — |
ROA | 9.3% | — | — |
Current Ratio | $5.281 | — | — |
Debt to Equity | $0.277 | — | — |
Other companies in Biotechnology